The primary responsibility of the independent Data
Site Search
Through efficient study design, optimized clinical trial execution, and high-quality data, the Therapeutics Development Network (TDN) helps speed the delivery of new and better therapies to people with cystic fibrosis.
Effective clinical development plans and good study design can save sponsors and investigators time and money, leading to faster development of potential new therapies for people with cystic fibrosis.
The Therapeutics Development Network includes over 90
Therapeutics Development Network investigators and research staff work every day to promote quality,
Access to antimicrobial tools can aid researchers in the discovery of new anti-infective treatments for cystic fibrosis.
Cystic fibrosis biological samples are available to qualified researchers to help develop promising new studies that will support CF research and aid in drug development and drug discovery.
The CFTR Antibodies Distribution Program works to streamline access to reagents specific for the detection of cystic fibrosis transmembrane conductance regulator (CFTR) expression.
Various assays for measuring cystic fibrosis transmembrane conductance regulator (